Mutant RNA contributes to neuropathology in new mouse models of Huntington’s disease
Ontology highlight
ABSTRACT: Huntington’s disease (HD) is a neurodegenerative polyglutamine (polyQ) disease resulting from the expansion of CAG repeats located in the ORF of the huntingtin gene (HTT). The extent to which mutant mRNA-driven disruptions contribute to HD pathogenesis, particularly in comparison to the dominant mechanisms related to the gain-of-function effects of the mutant polyQ protein, is still a subject of debate. To evaluate the contribution of mutant RNA to HD pathogenesis in vivo, we generated two mouse models through knock‐in strategy at the Rosa26 locus. These models expressed distinct variants of human mutant HTT cDNA fragment: a translated variant (HD/100Q model, serving as a reference) and a nontranslated variant (HD/100CAG model). The cohorts of animals were subjected to a broad spectrum of molecular, behavioral and cognitive analysis for 21 months. Behavioral testing revealed a progressive phenotype in both models, with the HD/100Q model exhibiting a more severe phenotype. The rotarod, static rod and open-field tests showed motor deficits in HD/100CAG and HD/100Q model mice during the light phase, while ActiMot indicated hyperkinesis during the dark phase. Both models also exhibited certain striatal transcriptionopathy. In conclusion, we provide in vivo evidence for a contributory role of mutant RNA in HD pathogenesis. The separated effects resulting from the presence of mutant RNA in the HD/100CAG model led to less severe but, to some extent, similar types of impairments (such as increased anxiety) as in the HD/100Q model.
ORGANISM(S): Mus musculus
PROVIDER: GSE269068 | GEO | 2024/06/23
REPOSITORIES: GEO
ACCESS DATA